Charles Schwab’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.52M | Sell |
1,293,016
-81,858
| -6% | -$413K | ﹤0.01% | 2220 |
|
|
2025
Q1 | $8.91M | Buy |
1,374,874
+122,219
| +10% | +$792K | ﹤0.01% | 2004 |
|
|
2024
Q4 | $9.19M | Buy |
1,252,655
+118,379
| +10% | +$869K | ﹤0.01% | 2054 |
|
|
2024
Q3 | $8.5M | Buy |
1,134,276
+136,087
| +14% | +$1.02M | ﹤0.01% | 2109 |
|
|
2024
Q2 | $8.88M | Buy |
998,189
+168,878
| +20% | +$1.5M | ﹤0.01% | 2102 |
|
|
2024
Q1 | $8.4M | Buy |
829,311
+76,238
| +10% | +$772K | ﹤0.01% | 2070 |
|
|
2023
Q4 | $7.58M | Buy |
753,073
+31,405
| +4% | +$316K | ﹤0.01% | 2134 |
|
|
2023
Q3 | $6.76M | Buy |
721,668
+84,694
| +13% | +$794K | ﹤0.01% | 2114 |
|
|
2023
Q2 | $15.6M | Buy |
636,974
+26,817
| +4% | +$658K | ﹤0.01% | 1665 |
|
|
2023
Q1 | $14.2M | Sell |
610,157
-124,590
| -17% | -$2.9M | ﹤0.01% | 1699 |
|
|
2022
Q4 | $18.6M | Buy |
734,747
+83,374
| +13% | +$2.11M | 0.01% | 1499 |
|
|
2022
Q3 | $12.6M | Sell |
651,373
-118,191
| -15% | -$2.28M | ﹤0.01% | 1686 |
|
|
2022
Q2 | $19.6M | Buy |
769,564
+24,236
| +3% | +$617K | 0.01% | 1423 |
|
|
2022
Q1 | $19.2M | Buy |
745,328
+18,792
| +3% | +$483K | 0.01% | 1583 |
|
|
2021
Q4 | $30.4M | Buy |
726,536
+27,892
| +4% | +$1.17M | 0.01% | 1254 |
|
|
2021
Q3 | $30.4M | Buy |
698,644
+110,188
| +19% | +$4.8M | 0.01% | 1216 |
|
|
2021
Q2 | $27.8M | Buy |
588,456
+31,284
| +6% | +$1.48M | 0.01% | 1311 |
|
|
2021
Q1 | $28.6M | Buy |
557,172
+14,801
| +3% | +$759K | 0.01% | 1226 |
|
|
2020
Q4 | $14.5M | Buy |
542,371
+5,936
| +1% | +$159K | 0.01% | 1626 |
|
|
2020
Q3 | $18.4M | Buy |
536,435
+435,872
| +433% | +$15M | 0.01% | 1255 |
|
|
2020
Q2 | $4.12M | Buy |
100,563
+85,366
| +562% | +$3.5M | ﹤0.01% | 2113 |
|
|
2020
Q1 | $521K | Sell |
15,197
-269
| -2% | -$9.22K | ﹤0.01% | 2701 |
|
|
2019
Q4 | $195K | Buy |
+15,466
| New | +$195K | ﹤0.01% | 3041 |
|